NCT03629301

Brief Summary

In Mexico, 7 out of 10 adults are overweight or obese. The diseases associated with these conditions (diabetes, cardiovascular disease and some cancers) are those that impact the most on the disability-adjusted life years of Mexicans and on their mortality rates. A reduction in body weight of 5-10% can reduce the incidence of obesity related diseases. The gold standard for treating obesity is an intensive lifestyle change program such as the Diabetes Prevention Program (DPP) whose effectiveness has been evaluated in various formats and populations with positive results, including in Mexico. However, the DPP is not accessible to all sectors of the population. To increase its dissemination, the implementation of online interventions based on the DPP (oi-DPP) has been proposed. A systematic review of oi-DPP showed promising results, however, the evidence is limited and the lack of studies of high methodological quality is highlighted. The main objective of this project is to evaluate the efficacy of an oi-DPP for weight loss in Mexican adults with overweight or obesity at 3 months. The study design is a randomized controlled trial with 2 arms: oi-DPP and wait-list control. A 3 months pilot study (n=30) will be conducted prior to the main study to estimate sample size, considering an alpha error of 0.05 and power of 80%. The primary outcome is the mean change in body weight from baseline to 3 months post-baseline between the 2 groups. Secondarily, differences in biochemical parameters (fasting glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides and gamma glutamyl transferase) from baseline to 3 months will be evaluated, as well as mean changes from baseline to 3 and 6 months in body mass index, waist circumference, systolic and diastolic blood pressure, depression and quality of life scales and the number of participants achieving a weight loss greater than 5% of initial body weight. Body weight will be also evaluated at 6 months post-baseline. The previous measurements will apply both in the pilot study and the study except for the biochemical parameters that will only be included in the main study. The differences between the 2 groups for each variable will be analyzed using a t test for independent samples, in case of having a parametric sample. Otherwise, the Mann-Whitney U test will be used. Analysis will follow the intent-to-treat principle.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

September 17, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2019

Completed
Last Updated

April 28, 2021

Status Verified

April 1, 2021

Enrollment Period

11 months

First QC Date

August 10, 2018

Last Update Submit

April 27, 2021

Conditions

Keywords

ObesityOverweightLifestyle InterventionRandomized controlled TrialInternet deliveredOnlineWeight loss

Outcome Measures

Primary Outcomes (1)

  • Change in body weight

    baseline to 3 months

Secondary Outcomes (14)

  • Change in body weight

    baseline to 6 months

  • Change in body mass index

    baseline to 3 months and baseline to 6 months

  • Change in waist circumference

    baseline to 3 months and baseline to 6 months

  • Change in body fat percentage

    baseline to 3 months and baseline to 6 months

  • Change in the Beck Depression Inventory Scale

    baseline to 3 months and baseline to 6 months

  • +9 more secondary outcomes

Study Arms (2)

ID-DPP group

EXPERIMENTAL

Internet-delivered intervention based on the DPP

Behavioral: ID-DPP group

Wait-list Group

OTHER
Other: Wait-list Group

Interventions

ID-DPP groupBEHAVIORAL

This group will receive a 6 month long online behavioral change protocol adapted from the Diabetes Prevention Program. It includes 18 sessions, 12 delivered weekly (during the first 3 months) and 6 delivered biweekly (during the last 3 month period). A web page will be used to deliver the sessions, while the nutritional counseling will be delivered using video calls via Facebook chat. Participants will receive an hypocaloric (1200-1800 kcal, carbohydrates: 45-65%, fats: 20-35% and protein: 10-35%), personalized diet.

ID-DPP group

This group will only receive written information with recommendations on healthy eating. When the study has finished this group will receive a behavioral change protocol with nutritional counseling using a face-to-face format.

Wait-list Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Mexican adults (≥ 18 years and ≤60)
  • Residents of the city of Hermosillo, Sonora
  • Overweight or obese (BMI ≥ 25 and ≤45)
  • Internet access at home
  • Basic computer skills
  • Facebook active account
  • Candidates must make records of their food consumption for 5 days.

You may not qualify if:

  • Substance abuse
  • Consumption of more than 14 alcoholic beverages per week (equivalent to 280 g of alcohol)
  • Diagnosis of psychiatric conditions that could prevent adherence to treatment
  • Previous diagnosis of medical conditions with significant effect on body weight
  • Diagnosis of diabetes
  • Systolic blood pressure\> 160 mm / Hg
  • Pregnant women who are breastfeeding or who plan to become pregnant during the study period
  • Consumption of medications with an effect on body weight such as metformin, orlistat or glucocorticoids.
  • Participating in another program to reduce weight or performing structured physical exercise other than walking\> 180 min / week
  • Plan to participate in some treatment for weight loss during the study
  • Any other condition in which weight loss or physical activity is contraindicated
  • Previous diagnosis of kidney failure, cancer or any other condition that requires special treatment
  • Relatives participating in the study
  • Have plans to change residence
  • Criteria of the researcher - for clinical reasons or adherence to the protocol
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Promoción de Salud Nutricional (CPSN)

Hermosillo, Sonora, 83000, Mexico

Location

Related Publications (1)

  • Ruelas AL, Martinez Contreras TJ, Esparza Romero J, Diaz Zavala RG, Candia Plata MDC, Hingle M, Armenta Guirado B, Haby MM. Factors influencing adults to drop out of intensive lifestyle interventions for weight loss. Transl Behav Med. 2023 Apr 15;13(4):245-254. doi: 10.1093/tbm/ibac112.

MeSH Terms

Conditions

ObesityOverweightWeight Loss

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 10, 2018

First Posted

August 14, 2018

Study Start

September 17, 2018

Primary Completion

July 31, 2019

Study Completion

October 30, 2019

Last Updated

April 28, 2021

Record last verified: 2021-04

Locations